These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18461501)

  • 1. Plasmacytoid dendritic cells and interferon-alpha in Aicardi-Goutières syndrome.
    van Heteren JT; van der Knaap MS; Poll The BW; Kuijpers TW
    Neuropediatrics; 2007 Dec; 38(6):269-75. PubMed ID: 18461501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.
    Lövgren T; Eloranta ML; Båve U; Alm GV; Rönnblom L
    Arthritis Rheum; 2004 Jun; 50(6):1861-72. PubMed ID: 15188363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.
    Båve U; Nordmark G; Lövgren T; Rönnelid J; Cajander S; Eloranta ML; Alm GV; Rönnblom L
    Arthritis Rheum; 2005 Apr; 52(4):1185-95. PubMed ID: 15818675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.
    Lövgren T; Eloranta ML; Kastner B; Wahren-Herlenius M; Alm GV; Rönnblom L
    Arthritis Rheum; 2006 Jun; 54(6):1917-27. PubMed ID: 16729300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
    Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.
    Lood C; Gullstrand B; Truedsson L; Olin AI; Alm GV; Rönnblom L; Sturfelt G; Eloranta ML; Bengtsson AA
    Arthritis Rheum; 2009 Oct; 60(10):3081-90. PubMed ID: 19790049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
    Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
    Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells.
    Eloranta ML; Lövgren T; Finke D; Mathsson L; Rönnelid J; Kastner B; Alm GV; Rönnblom L
    Arthritis Rheum; 2009 Aug; 60(8):2418-27. PubMed ID: 19644885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus.
    Means TK; Luster AD
    Ann N Y Acad Sci; 2005 Dec; 1062():242-51. PubMed ID: 16461805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus.
    Batteux F; Palmer P; Daëron M; Weill B; Lebon P
    Eur Cytokine Netw; 1999 Dec; 10(4):509-14. PubMed ID: 10586117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.
    Barrat FJ; Meeker T; Gregorio J; Chan JH; Uematsu S; Akira S; Chang B; Duramad O; Coffman RL
    J Exp Med; 2005 Oct; 202(8):1131-9. PubMed ID: 16230478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
    Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.
    Nordmark G; Alm GV; Rönnblom L
    Nat Clin Pract Rheumatol; 2006 May; 2(5):262-9. PubMed ID: 16932699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of natural interferon-alpha producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines.
    Båve U; Vallin H; Alm GV; Rönnblom L
    J Autoimmun; 2001 Aug; 17(1):71-80. PubMed ID: 11488639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic increase in type I interferon activity in Sjögren's syndrome: a putative role for plasmacytoid dendritic cells.
    Wildenberg ME; van Helden-Meeuwsen CG; van de Merwe JP; Drexhage HA; Versnel MA
    Eur J Immunol; 2008 Jul; 38(7):2024-33. PubMed ID: 18581327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.